Dark

BOLD
Boundless Bio, Inc. Common Stock
stock NASDAQ

Market Open

May 1, 2026 3:21:31 PM EDT

1.53USD+5.137%(+0.07)49,421

1.30Bid 1.74Ask 0.44Spread

Pre-market

Apr 30, 2026 8:01:30 AM EDT

1.44USD-1.130%(-0.02)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsMore

open chart

Market Cap

34.40M

Headquarters

CA, USA

Industry

Biotechnology

Next Earnings

May 8, 2026 (7d)

PDLI PIRS XLV

BOLD Stats

Avg. Vol. 10 Day

138,147

Avg. Vol. 30 Day

341,642

Employees

152

Market Cap

34,395,130

Shares Out.

22,407,251

On/Off Exchange

38%/62%

6 Month Beta

0.79

1 Year Beta

0.69

2 Year Beta

1.17

3 Year Beta

1.21

52 Week Low

0.96

52 Week High

1.78

SMA50

1.24

SMA200

1.21

1 Week

+2.33%

1 Month

+35.84%

3 Month

+35.84%

6 Month

+9.64%

1 Year

-4.66%

2 Year

-84.65%

5 Year

-97.44%

Profile

Audentes Therapeutics Inc is a biotechnology company. It is engaged in developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects.

BOLD Stock Summary

Boundless Bio, Inc. Common Stock (NASDAQ:BOLD) stock price today is $1.53, and today's volume is 49,421. BOLD is up 5.137% today. The 30 day average volume is 341,642. BOLD market cap is 34.40M with 22,407,251 shares outstanding.